Lantern Pharma, Inc. is a clinical-stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data, and precision oncology trials. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.

Biotechnology

Lantern Pharma

Panna Sharma

Marc Chamberlain

Michelle Harding

Reggie Ewesuedo

David Margrave

Kishor G. Bhatia

Peter Carr

Drug Development Team

Clinical Team

Data Science Team

Executive Team

��

Drug Development Team

Team members

��������

Drug Development Team

Team members

��